長期投資家のためのIR情報
バリュートレンド

【4151】協和キリン
医薬品、バイオケミカル。親会社はキリンHLD。

業績予想修正履歴

決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2024.12 2024/02/07 当初予 473,000 - - - 85,000 - - - 85,000 - - - 63,000 - - -
2023.12 2024/02/07 442,233 +3.8% +3.8% 97,246 +13.1% +3.5% 97,246 +13.1% +3.5% 81,188 +16.0% +6.8%
2023.12 2023/11/01 Q3予 426,000 0.0% 0.0% 86,000 0.0% -8.5% 86,000 0.0% -8.5% 70,000 0.0% -7.9%
2023.12 2023/08/03 Q2予 426,000 0.0% 0.0% 86,000 0.0% -8.5% 86,000 0.0% -8.5% 70,000 0.0% -7.9%
2023.12 2023/05/10 Q1予 426,000 0.0% 0.0% 86,000 -8.5% -8.5% 86,000 -8.5% -8.5% 70,000 -7.9% -7.9%
2023.12 2023/02/07 当初予 426,000 - - - 94,000 - - - 94,000 - - - 76,000 - - -
2022.12 2023/02/07 398,371 -0.4% +4.8% 67,572 +4.0% +2.4% 67,572 +4.0% +2.4% 53,573 +1.1% +1.1%
2022.12 2022/12/06 修正予 400,000 0.0% +5.3% 65,000 -1.5% -1.5% 65,000 -17.7% -1.5% 53,000 -15.9% 0.0%
2022.12 2022/11/04 Q3予 400,000 0.0% +5.3% - - - - 79,000 0.0% +19.7% 63,000 0.0% +18.9%
2022.12 2022/08/04 Q2予 400,000 +5.3% +5.3% - - - - 79,000 +19.7% +19.7% 63,000 +18.9% +18.9%
2022.12 2022/05/10 Q1予 380,000 0.0% 0.0% - - - - 66,000 0.0% 0.0% 53,000 0.0% 0.0%
2022.12 2022/02/07 当初予 380,000 - - - 66,000 - - - 66,000 - - - 53,000 - - -
2021.12 2022/02/07 352,246 +0.4% +0.4% 60,050 -7.6% -6.2% 60,050 -6.2% -6.2% 52,347 +4.7% +4.7%
2021.12 2021/11/01 Q3予 351,000 0.0% 0.0% 65,000 +1.6% +1.6% 64,000 0.0% 0.0% 50,000 0.0% 0.0%
2021.12 2021/08/03 Q2予 351,000 0.0% 0.0% - - - - 64,000 0.0% 0.0% 50,000 0.0% 0.0%
2021.12 2021/05/06 Q1予 351,000 0.0% 0.0% - - - - 64,000 0.0% 0.0% 50,000 0.0% 0.0%
2021.12 2021/02/04 当初予 351,000 - - - 64,000 - - - 64,000 - - - 50,000 - - -
2020.12 2021/02/04 318,352 +1.7% -2.6% 52,263 -17.0% -17.0% 52,263 -1.4% -17.0% 47,027 +6.9% -4.0%
2020.12 2020/10/30 Q3予 313,000 0.0% -4.3% - - - - 53,000 0.0% -15.9% 44,000 0.0% -10.2%
2020.12 2020/07/30 Q2予 313,000 -4.3% -4.3% - - - - 53,000 -15.9% -15.9% 44,000 -10.2% -10.2%
2020.12 2020/05/01 Q1予 327,000 0.0% 0.0% - - - - 63,000 0.0% 0.0% 49,000 0.0% 0.0%
2020.12 2020/02/05 当初予 327,000 - - - 63,000 - - - 63,000 - - - 49,000 - - -
2019.12 2020/02/05 305,820 +0.3% +0.3% 44,492 -5.3% -5.3% 44,492 -5.3% -5.3% 67,084 -1.3% -1.3%
2019.12 2019/10/29 Q3予 305,000 0.0% 0.0% - - - - 47,000 0.0% 0.0% 68,000 0.0% 0.0%
2019.12 2019/08/01 Q2予 305,000 0.0% 0.0% - - - - 47,000 0.0% 0.0% 68,000 0.0% 0.0%
2019.12 2019/05/08 Q1予 305,000 0.0% 0.0% - - - - 47,000 0.0% 0.0% 68,000 0.0% 0.0%
2019.12 2019/02/05 当初予 305,000 - - - 47,000 - - - 47,000 - - - 68,000 - - -
2018.12 2019/02/05 346,531 +3.4% +3.4% 73,438 +20.4% +20.4% 73,438 +3.4% +20.4% 54,414 +4.6% +23.7%
2018.12 2018/10/30 Q3予 335,000 0.0% 0.0% - - - - 71,000 +16.4% +16.4% 52,000 +18.2% +18.2%
2018.12 2018/07/31 Q2予 335,000 0.0% 0.0% - - - - 61,000 0.0% 0.0% 44,000 0.0% 0.0%
2018.12 2018/05/08 Q1予 335,000 0.0% 0.0% - - - - 61,000 0.0% 0.0% 44,000 0.0% 0.0%
2018.12 2018/02/08 当初予 335,000 - - - 61,000 - - - 61,000 - - - 44,000 - - -
2017.12 2018/02/08 353,380 +1.8% +2.7% 55,849 +43.2% +59.6% 55,849 +59.6% +86.2% 42,899 +104.3% +125.8%
2017.12 2017/10/26 Q3予 347,000 0.0% +0.9% 39,000 0.0% +11.4% 35,000 0.0% +16.7% 21,000 0.0% +10.5%
2017.12 2017/07/28 Q2予 347,000 +0.9% +0.9% 39,000 +11.4% +11.4% 35,000 +16.7% +16.7% 21,000 +10.5% +10.5%
2017.12 2017/04/27 Q1予 344,000 0.0% 0.0% 35,000 0.0% 0.0% 30,000 0.0% 0.0% 19,000 0.0% 0.0%
2017.12 2017/01/31 当初予 344,000 - - - 35,000 - - - 30,000 - - - 19,000 - - -
2016.12 2017/01/31 343,019 -0.3% -2.3% 31,638 -1.1% +5.5% 26,397 +1.5% -12.0% 18,669 +3.7% +16.7%
2016.12 2016/10/28 Q3予 344,000 0.0% -2.0% 32,000 0.0% +6.7% 26,000 0.0% -13.3% 18,000 0.0% +12.5%
2016.12 2016/07/29 Q2予 344,000 0.0% -2.0% - - - - 26,000 -18.8% -13.3% 18,000 0.0% +12.5%
2016.12 2016/07/21 修正予 344,000 -2.0% -2.0% 32,000 +6.7% +6.7% 32,000 +6.7% +6.7% 18,000 +12.5% +12.5%
2016.12 2016/04/27 Q1予 351,000 0.0% 0.0% 30,000 0.0% 0.0% 30,000 0.0% 0.0% 16,000 0.0% 0.0%
2016.12 2016/01/29 当初予 351,000 - - - 30,000 - - - 30,000 - - - 16,000 - - -
2015.12 2016/01/29 364,316 +1.2% +2.9% 43,765 -6.9% +5.5% 39,203 -4.4% -5.5% 29,774 +14.5% +60.9%
2015.12 2015/10/28 Q3予 360,000 0.0% +1.7% 47,000 0.0% +13.3% 41,000 0.0% -1.2% 26,000 0.0% +40.5%
2015.12 2015/07/31 Q2予 360,000 0.0% +1.7% 47,000 0.0% +13.3% 41,000 -12.8% -1.2% 26,000 0.0% +40.5%
2015.12 2015/07/24 修正予 360,000 +1.7% +1.7% 47,000 +13.3% +13.3% 47,000 +13.3% +13.3% 26,000 +40.5% +40.5%
2015.12 2015/04/28 Q1予 354,000 0.0% 0.0% 41,500 0.0% 0.0% 41,500 0.0% 0.0% 18,500 0.0% 0.0%
2015.12 2015/01/30 当初予 354,000 - - - 41,500 - - - 41,500 - - - 18,500 - - -
2014.12 2015/01/30 333,446 -0.8% -1.1% 36,173 -15.9% -11.8% 29,511 -15.7% -28.0% 15,898 -11.7% -20.5%
2014.12 2014/10/28 Q3予 336,000 -0.3% -0.3% 43,000 -4.4% +4.9% 35,000 -5.4% -14.6% 18,000 -10.0% -10.0%
2014.12 2014/07/30 Q2予 337,000 0.0% 0.0% 45,000 +9.8% +9.8% 37,000 -9.8% -9.8% 20,000 0.0% 0.0%
2014.12 2014/04/24 Q1予 337,000 0.0% 0.0% 41,000 0.0% 0.0% 41,000 0.0% 0.0% 20,000 0.0% 0.0%
2014.12 2014/01/31 当初予 337,000 - - - 41,000 - - - 41,000 - - - 20,000 - - -
2013.12 2014/01/31 340,611 - - - 51,773 - - - 49,502 - - - 30,078 - - -
ページトップへ戻る